Zobrazeno 1 - 10
of 250
pro vyhledávání: '"Jacques, Barbet"'
Autor:
Jacques Barbet, Myriam Bernaudin, Pierre Payoux, Francesco Cicone, Marie-Hélène Gaugler, Françoise Kraeber-Bodéré
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Externí odkaz:
https://doaj.org/article/f6f29ebaf0074b29bb7b98917916be3d
Autor:
Justine Perrin, Marisa Capitao, Marie Mougin-Degraef, François Guérard, Alain Faivre-Chauvet, Latifa Rbah-Vidal, Joëlle Gaschet, Yannick Guilloux, Françoise Kraeber-Bodéré, Michel Chérel, Jacques Barbet
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
The impressive development of cancer immunotherapy in the last few years originates from a more precise understanding of control mechanisms in the immune system leading to the discovery of new targets and new therapeutic tools. Since different stages
Externí odkaz:
https://doaj.org/article/917a62510146415d8739dae10daa49e9
Autor:
Judith Anna Delage, Silvano Gnesin, John O. Prior, Jacques Barbet, Patricia Le Saëc, Séverine Marionneau-Lambot, Sébastien Gouard, Michel Chérel, Mickael Bourgeois, Niklaus Schaefer, David Viertl, Julie Katrin Fierle, Steven Mark Dunn, Alain Faivre-Chauvet
Publikováno v:
Cancers, Vol 13, Iss 23, p 5936 (2021)
1C1m-Fc, a promising anti-TEM-1 DOTA conjugate, was labeled with 64Cu to target cancer cells for PET imaging and predicting the efficacy and safety of a previously studied [177Lu]Lu-1C1m-Fc companion therapy. DOTA-conjugated 1C1m-Fc was characterized
Externí odkaz:
https://doaj.org/article/8a3bbf681cfe4069b13366e861a99520
Autor:
Fijs W. B. van Leeuwen, Bart Cornelissen, Federico Caobelli, Laura Evangelista, Latifa Rbah-Vidal, Silvana Del Vecchio, Catarina Xavier, Jacques Barbet, Marion de Jong
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 2, Iss 1, Pp 1-6 (2017)
Abstract Given the increasing exploration of fluorescent tracers in the field of nuclear medicine, a need has risen for practical development guidelines that can help improve the translation aspects of fluorescent tracers. This editorial discusses th
Externí odkaz:
https://doaj.org/article/aecf421a1b7a490b8bfece6056904b72
Autor:
Clément Bailly, Caroline Bodet-Milin, Caroline Rousseau, Alain Faivre-Chauvet, Françoise Kraeber-Bodéré, Jacques Barbet
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 2, Iss 1, Pp 1-14 (2017)
Abstract Background Oncological pretargeting has been implemented and tested in several different ways in preclinical models and clinical trials over more than 30 years. Despite highly promising results, pretargeting has not achieved market approval
Externí odkaz:
https://doaj.org/article/d8551b493b254c6699eda614f4cadf5d
Autor:
David Teze, Dumitru-Claudiu Sergentu, Valentina Kalichuk, Jacques Barbet, David Deniaud, Nicolas Galland, Rémi Maurice, Gilles Montavon
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract 211At is a most promising radionuclide for targeted alpha therapy. However, its limited availability and poorly known basic chemistry hamper its use. Based on the analogy with iodine, labelling is performed via astatobenzoate conjugates, but
Externí odkaz:
https://doaj.org/article/ed78f40f24454144bfa69cd69a69a850
Autor:
Caroline Bodet-Milin, Clément Bailly, Yann Touchefeu, Eric Frampas, Mickael Bourgeois, Aurore Rauscher, Franck Lacoeuille, Delphine Drui, Nicolas Arlicot, David M. Goldenberg, Alain Faivre-Chauvet, Jacques Barbet, Caroline Rousseau, Françoise Kraeber-Bodéré
Publikováno v:
Frontiers in Medicine, Vol 6 (2019)
Monoclonal antibody (mAb)-based therapies have experienced considerable growth in cancer management. When labeled with radionuclides, mAbs also represent promising probes for imaging or theranostic approaches. Initially, mAbs have been radiolabeled w
Externí odkaz:
https://doaj.org/article/84f344d109794441b254c9b9cb7783b9
Autor:
Judith Anna Delage, Alain Faivre-Chauvet, Jacques Barbet, Julie Katrin Fierle, Niklaus Schaefer, George Coukos, David Viertl, Steven Mark Dunn, Silvano Gnesin, John O. Prior
Publikováno v:
Pharmaceutics, Vol 13, Iss 1, p 96 (2021)
1C1m-Fc, an anti-tumor endothelial marker 1 (TEM-1) scFv-Fc fusion protein antibody, was previously successfully radiolabeled with 177Lu. TEM-1 specific tumor uptake was observed together with a non-saturation dependent liver uptake that could be rel
Externí odkaz:
https://doaj.org/article/b9a323a8b9be4b5b9e09a874af5200aa
Autor:
Françoise Kraeber-Bodéré, Caroline Rousseau, Caroline Bodet-Milin, Cédric Mathieu, François Guérard, Eric Frampas, Thomas Carlier, Nicolas Chouin, Ferid Haddad, Jean-François Chatal, Alain Faivre-Chauvet, Michel Chérel, Jacques Barbet
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 2, Pp 3932-3954 (2015)
This paper reviews some aspects and recent developments in the use of antibodies to target radionuclides for tumor imaging and therapy. While radiolabeled antibodies have been considered for many years in this context, only a few have reached the lev
Externí odkaz:
https://doaj.org/article/48f3001a0dda4beab5e565506ebb1458
Publikováno v:
médecine/sciences. 35:1062-1065